Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Graduate Program in Cell and Molecular Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Department of Cancer Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, USA; Institute for Regenerative Medicine, University of Pennsylvania, Philadelphia, PA, USA; Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA, USA.
Trends Cancer. 2020 Dec;6(12):1059-1067. doi: 10.1016/j.trecan.2020.07.005. Epub 2020 Aug 14.
Over the past decade, several landmark reports have demonstrated that the nervous system plays an active role in cancer initiation and progression. These studies demonstrate that ablation of specific nerve types (parasympathetic, sympathetic, or sensory) abrogates tumor growth in a tissue-specific manner. Further, many tumor types are more densely innervated than their normal tissues of origin. These striking results raise fundamental questions regarding tumor innervation, how it is initiated, and how it molecularly contributes to disease. In this review, we aim to address what is currently known about the origin of tumor-infiltrating nerves, how they may be recruited to tumors, and how their presence may give rise to aggressive disease.
在过去的十年中,有几项具有里程碑意义的报告表明神经系统在癌症的发生和发展中发挥着积极作用。这些研究表明,特定神经类型(副交感神经、交感神经或感觉神经)的消融以组织特异性的方式阻止了肿瘤的生长。此外,许多肿瘤类型的神经支配密度比其正常起源组织更高。这些惊人的结果提出了关于肿瘤神经支配的基本问题,包括它是如何开始的,以及它如何在分子水平上促进疾病的发展。在这篇综述中,我们旨在探讨目前已知的肿瘤浸润神经的起源、它们如何被招募到肿瘤中,以及它们的存在如何导致侵袭性疾病。